Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Treasury Shares (2019 - 2025)

aTYR PHARMA's Treasury Shares history spans 7 years, with the latest figure at $20108.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 51.21% year-over-year to $20108.0; the TTM value through Dec 2025 reached $20108.0, down 51.21%, while the annual FY2025 figure was $20108.0, 51.21% down from the prior year.
  • Treasury Shares reached $20108.0 in Q4 2025 per ATYR's latest filing, roughly flat from $20108.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $121438.0 in Q2 2022 to a low of $7500.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $50717.8, with a median of $41216.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: surged 1519.17% in 2022, then plummeted 58.5% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $7500.0 in 2021, then skyrocketed by 1519.17% to $121438.0 in 2022, then plummeted by 47.85% to $63327.0 in 2023, then plummeted by 34.92% to $41216.0 in 2024, then tumbled by 51.21% to $20108.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Treasury Shares are $20108.0 (Q4 2025), $20108.0 (Q3 2025), and $20108.0 (Q2 2025).